-
公开(公告)号:EP4452944A1
公开(公告)日:2024-10-30
申请号:EP22850858.6
申请日:2022-12-19
发明人: CHAPMAN, Mark , DAVIES, Nicholas Gareth, Morse , GERLACH, Aaron , GRAHAM, Christopher, John , LEBRETON, Sylvain , LI, Ronghua , MA, Nina , MADDOX, Daniel , MECHIN, Ingrid , MOWREY, David , NAGARAJAN, Karthigeyan , NAIR, Anil , NORCROSS, Roger, David , REDONDO PENA, Roger Lluis , SAFAROVA, Alena , SMRCINA, Martin
IPC分类号: C07D213/57 , C07D213/61 , C07D239/34 , C07D403/04 , C07D407/04 , C07D407/12 , C07D413/04 , C07D417/04 , A61K31/44 , A61K31/513 , A61P25/00
-
公开(公告)号:EP3707125A1
公开(公告)日:2020-09-16
申请号:EP18816306.7
申请日:2018-11-09
发明人: PRIEBE, Waldemar , SKORA, Stanislaw , FOKT, Izabela , ZIELINSKI, Rafal , JAYAKUMAR, Arumugan , VENUGOPAL, Radjendirane
IPC分类号: C07D213/61 , C07D213/57 , A61P35/00 , A61K31/44
-
公开(公告)号:EP3119755A4
公开(公告)日:2017-08-23
申请号:EP15764771
申请日:2015-03-19
申请人: VIAMET PHARMACEUTICALS INC , THE U S A AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
发明人: HOEKSTRA WILLIAM J , YATES CHRISTOPHER M , BEHNKE MARK , ALIMARDANOV ASAF , DAVID SCOTT A , FRY DOUGLAS FRANKLIN
IPC分类号: C07D401/06 , A61K31/04 , A61K31/41 , A61K31/4439 , C07D213/57 , C07F7/18
CPC分类号: C07D401/06 , A61K31/4439 , C07B57/00 , C07B2200/07 , C07D213/57 , C07F7/1856
摘要: The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 and substituted derivatives thereof.
-
4.SUBSTITUIERTE VINYL- UND ALKINYL-CYANOCYCLOALKANOLE SOWIE VINYL- UND ALKINYL-CYANOHETEROCYCLYLALKANOLE ALS WIRKSTOFFE GEGEN ABIOTISCHEN PFLANZENSTRESS 有权
标题翻译: 取代乙烯基和炔CYANOCYCLOALKANOLE和乙烯基和炔CYANOHETEROCYCLYLALKANOLE为活动对非生物植物胁迫公开(公告)号:EP3169662A1
公开(公告)日:2017-05-24
申请号:EP15736514.9
申请日:2015-07-14
发明人: FRACKENPOHL, Jens , WILLMS, Lothar , DITTGEN, Jan , RUIZ-SANTAELLA MORENO, Juan Pedro , SCHMUTZLER, Dirk , HILLS, Martin Jeffrey
IPC分类号: C07C255/46 , C07C255/51 , C07D305/08 , C07D213/80 , C07D213/57 , C07D211/60 , C07D207/16 , C07C311/08 , C07C311/14 , C07C311/16 , C07C311/20 , C07C323/03 , C07F5/02 , C07F7/00 , C07F7/18 , C07F7/22
CPC分类号: C07C255/46 , A01N37/34 , A01N37/36 , A01N43/20 , A01N53/00 , A01N55/00 , A01N55/08 , C07C255/51 , C07C311/08 , C07C311/14 , C07C311/16 , C07C311/20 , C07C323/03 , C07C2101/02 , C07C2101/04 , C07C2601/02 , C07C2601/04 , C07C2601/08 , C07C2601/14 , C07C2603/74 , C07D207/16 , C07D211/60 , C07D213/57 , C07D213/80 , C07D305/08 , C07F5/025 , C07F7/006 , C07F7/1856 , C07F7/2212 , C07F7/30
摘要: The invention relates to substituted vinyl and alkynyl cyanocycloalkanols and vinyl and alkynyl cyanoheterocyclylalkanols of general formula (I) or the salts thereof, wherein [X-Y], Q, R
1 , R
2 , A
1 , A
2 , V, W, m and n have the definitions specified in the description, process for their preparation and their use for increasing the stress tolerance in plants against abiotic stress and/or for increasing plant yield.摘要翻译: 本发明涉及substituiertem乙烯基和炔cyanocycloalkanols和通式(I)的乙烯基和炔cyanoheterocyclylalkanols或其盐,worin [XY],Q,R1,R2,A1,A2,V,W,m和n具有与定义 在描述中,其制备方法及其在植物对非生物应力增加胁迫耐受性和/或用于增加植物产量的使用规定。
-
公开(公告)号:EP1853261B1
公开(公告)日:2017-01-11
申请号:EP06708611.6
申请日:2006-03-02
IPC分类号: A61K31/4406 , A61K31/4709 , A61K31/4164 , A61K31/505 , C07D213/16 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/57 , C07D233/54 , C07D239/30 , A61P5/40
CPC分类号: A61K31/4164 , A61K31/4406 , A61K31/4709 , A61K31/505 , C07D213/16 , C07D213/30 , C07D213/55 , C07D213/56 , C07D213/57 , C07D233/54 , C07D233/56 , C07D233/64 , C07D239/26 , C07D239/30 , C07D239/34 , C07D263/32
-
6.NOVEL FUSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE, DISPLAY APPARATUS, IMAGE INFORMATION PROCESSING APPARATUS, LIGHTING SYSTEM, AND IMAGE FORMING APPARATUS HAVING THE COMPOUND 有权
标题翻译: NEW稠合多环化合物和有机发光装置,显示装置,图像信息处理装置中,照明系统及摄像装置与此连接公开(公告)号:EP2882707A4
公开(公告)日:2016-03-23
申请号:EP13827088
申请日:2013-07-18
申请人: CANON KK
发明人: TAGAMI KEI , OHRUI HIROKI , IWAWAKI HIRONOBU , ITABASHI MASUMI , TAKAHASHI TETSUO , IKARI KENICHI , ISHII RYUJI , MURATSUBAKI MASANORI
IPC分类号: C07C255/51 , C07C13/62 , C07C255/52 , C07D209/86 , C07D213/24 , C07D213/53 , C07D213/57 , C07D215/12 , C07D217/18 , C07D235/14 , C07D235/18 , C09K11/06 , G03G15/04 , H01L51/00 , H01L51/50 , H05B33/08 , H05B33/14
CPC分类号: G03G15/04036 , C07C13/62 , C07C255/51 , C07C255/52 , C07C2603/18 , C07C2603/54 , C07D209/86 , C07D213/24 , C07D213/53 , C07D213/57 , C07D215/12 , C07D217/18 , C07D235/14 , C07D235/18 , C09K11/06 , C09K2211/1011 , C09K2211/1029 , H01L51/0056 , H01L51/0058 , H01L51/0067 , H01L51/0072 , H01L51/5012 , H01L51/5024 , H05B33/0896 , H05B33/14
-
公开(公告)号:EP2598480A1
公开(公告)日:2013-06-05
申请号:EP11749118.3
申请日:2011-07-27
发明人: FYFE, Matthew Colin Thor , ORTEGA MUÑOZ, Alberto , CASTRO-PALOMINO LARIA, Julio , MARTINELL PEDEMONTE, Marc , ESTIARTE-MARTÍNEZ, Maria de los Ángeles , VALLS VIDAL, Nuria
IPC分类号: C07D213/38 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/57 , C07D239/26 , C07D277/28 , C07D333/20 , C07D401/04 , C07D405/04 , C07D409/04 , C07C211/35 , C07C311/21 , A61K31/44 , A61P35/00
CPC分类号: C07C211/40 , C07B2200/07 , C07C215/64 , C07C217/74 , C07C255/53 , C07C255/54 , C07C255/59 , C07C311/08 , C07C311/09 , C07C311/21 , C07C2601/02 , C07D213/38 , C07D213/40 , C07D213/42 , C07D213/56 , C07D213/57 , C07D213/64 , C07D239/26 , C07D277/28 , C07D333/20 , C07D401/04 , C07D401/10 , C07D405/04 , C07D405/10 , C07D409/04 , C07D409/10
摘要: The invention relates to cyclopropylamine compounds, in particular the compounds of Formula (I), and their use in therapy, including e.g. in the treatment or prevention of cancer, a neurological disease or condition, or viral infection.
摘要翻译: 本发明涉及环丙胺化合物,特别是式(I)化合物及其在治疗中的用途,包括例如, 治疗或预防癌症,神经系统疾病或病症或病毒感染。
-
公开(公告)号:EP2501678A1
公开(公告)日:2012-09-26
申请号:EP10785016.6
申请日:2010-11-16
申请人: Novartis AG
IPC分类号: C07D213/30 , C07D213/57 , C07D213/61 , C07D401/04 , C07D405/04 , C07D409/04 , A61K31/44 , A61K31/443 , A61K31/4436 , A61K31/4439 , A61P9/12
CPC分类号: C07D213/57 , C07D213/30 , C07D213/61 , C07D401/04 , C07D405/04 , C07D409/04
摘要: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R
1 , R
2 , R
3 , R
4 , R
5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.-
公开(公告)号:EP2488496A1
公开(公告)日:2012-08-22
申请号:EP10763703.5
申请日:2010-10-11
申请人: Bayer CropScience AG
发明人: DUBOST, Christophe , VIDAL, Jacky , RINOLFI, Philippe , GROSJEAN-COURNOYER, Marie-Claire , ES-SAYED, Mazen , BENTING, Jürgen , WACHENDORFF-NEUMANN, Ulrike , NARABU, Shinichi , ISHIKAWA, Koichi , HADANO, Hiroyuki , GENIX, Pierre , VORS, Jean-Pierre , BECKER, Angela , GÖRGENS, Ulrich
IPC分类号: C07D213/57 , C07D417/12 , C07D401/12 , C07D307/54 , C07D333/24 , C07D213/12 , C07D261/08 , C07D207/337 , A01N43/40 , A01N43/48 , A01N43/74 , A01N43/36 , C07D413/12
CPC分类号: C07D213/46 , A01N43/40 , A01N43/54 , A01N43/56 , A01N43/58 , A01N43/76 , A01N43/78 , A01N43/80 , A01N55/00 , C07D207/337 , C07D213/12 , C07D213/57 , C07D261/08 , C07D307/54 , C07D333/24 , C07D401/12 , C07D409/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to aminopropenoate derivatives, the process of their preparation, intermediate compounds, their use as fungicide active agents, particularly in the form of fungicide compositions, and methods for the control of phytopathogenic fungi, notably of plants and in material protection, using these compounds or compositions.
-
10.
公开(公告)号:EP1722863B1
公开(公告)日:2012-02-08
申请号:EP04803467.2
申请日:2004-12-02
申请人: DSM IP Assets B.V.
发明人: BERG-SCHULTZ, Katja
IPC分类号: A61Q17/04 , A61Q17/00 , C07F7/18 , C07D263/56 , C07C49/835 , C07C225/22 , C07D249/20 , C07D249/18 , C07D413/04 , C07D309/34 , C07D213/57
CPC分类号: C07D413/04 , A61K8/11 , A61K8/585 , A61K2800/412 , A61Q17/04 , B01J13/14 , C07C225/22 , C07D213/57 , C07D235/18 , C07D249/20 , C07D263/57 , C07D309/34 , C07F7/1836 , Y10T428/2985 , Y10T428/2989
摘要: The invention provides a process for producing microcapsules with UV filter activity, wherein at least one type of crosslinkable chromophore with UV-A and/or UV-B and/or UV-C filter activity and optionally at least one type of crosslinkable monomer which does not have UV-A and/or UV-B and/or UV-C filter activity are subjected to a crosslinking reaction in the absence of non-crosslinkable chromophores with UV-A and/or UV-B and/or UV-C filter activity and microcapsules obtainable by this process.
-
-
-
-
-
-
-
-
-